Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eversea is a biotechnology company specializing in the development and production of sustainable, algae-based Omega-3 fatty acids. As a commercial brand of Mara Renewables Corporation, the company utilizes advanced microalgae fermentation technology to extract high-purity docosahexaenoic acid (DHA). Their products serve as a vegan and environmentally friendly alternative to traditional fish oil, targeting the infant nutrition, dietary supplement, and food and beverage industries. Eversea's proprietary process ensures a contaminant-free source of essential nutrients while reducing the impact on marine ecosystems. The company is currently in the commercial stage, providing various formulations of algal oil and powders to global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eversea.